Wednesday, December 20, 2017

API cost increase to hit pharma firms' profit

“Such a high dependency (on single source) means any disruption in the supply of APIs could potentially result in significant shortages of essential drugs in India,” said Ravind Mithe, partner, strategy & operations, KPMG. The high dependence has also been dubbed as a health security risk.”
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates